Research Article
Different Patterns of Bacterial Species and Antibiotic Susceptibility in Diabetic Foot Syndrome with and without Coexistent Ischemia
Table 3
Number of particular bacterial isolates in all patients with ischemic diabetic foot syndrome.
| | Number of isolates | Percent |
| Staphylococcus aureus MSS | 38 | 16.10% | Enterococcus faecalis | 26 | 11.02% | Acinetobacter baumannii MDR | 14 | 5.93% | Proteus mirabilis | 13 | 5.51% | Staphylococcus aureus MLSB | 13 | 5.51% | Staphylococcus aureus MRSA, MLSB | 11 | 4.66% | Pseudomonas aeruginosa | 10 | 4.24% | Enterobacter cloacae | 9 | 3.81% | Klebsiella pneumoniae | 9 | 3.81% | Escherichia coli | 8 | 3.39% | Enterococcus faecalis HLAR | 7 | 2.97% | Staphylococcus aureus MRSA | 7 | 2.97% | Streptococcus agalactiae | 7 | 2.97% | Acinetobacter baumannii | 6 | 2.54% | Morganella morganii | 4 | 1.69% | Proteus spp. | 4 | 1.69% | Streptococcus dysgalactiae | 4 | 1.69% | Enterococcus faecium | 3 | 1.27% | Streptococcus mitis | 3 | 1.27% | Streptococcus pyogenes | 3 | 1.27% | Actinomyces naeslundii | 2 | 0.85% | Citrobacter koseri | 2 | 0.85% | Clostridium sporogenes | 2 | 0.85% | Finegoldia magna | 2 | 0.85% | Klebsiella pneumoniae ESBL | 2 | 0.85% | Proteus vulgaris | 2 | 0.85% | Stenotrophomonas maltophilia | 2 | 0.85% | Streptococcus agalactiae MLSB | 2 | 0.85% | Streptococcus constellatus | 2 | 0.85% | Veillonella spp. | 2 | 0.85% | Anaerococcus prevotii | 1 | 0.42% | Bifidobacterium spp. | 1 | 0.42% | Clostridium innocuum | 1 | 0.42% | Enterobacter cloacae AMP C, ESBL | 1 | 0.42% | Enterobacter cloacae ESBL | 1 | 0.42% | Enterococcus faecium HLAR | 1 | 0.42% | Enterococcus faecium HLAR, VRE | 1 | 0.42% | Enterobacter aerogenes | 1 | 0.42% | Gemella morbillorum | 1 | 0.42% | Klebsiella oxytoca | 1 | 0.42% | Klebsiella pneumoniae MBL MDR | 1 | 0.42% | Klebsiella pneumoniae MDR | 1 | 0.42% | Lactobacillus fermentum | 1 | 0.42% | Prevotella spp. | 1 | 0.42% | Providencia stuartii ESBL, AMP C | 1 | 0.42% | Streptococcus dysgalactiae MLSB | 1 | 0.42% | Streptococcus spp. | 1 | 0.42% |
|
|
Abbreviations: MSS: methicillin-susceptible Staphylococcus; MDR: multiple drug resistant; MLSB: macrolide-lincosamide-streptogramin B resistance; MRSA: methicillin-resistant Staphylococcus aureus; HLAR: high-level aminoglycoside resistance; ESBL: extended spectrum beta-lactamase; AMP C: AmpC beta-lactamases; VRE: vancomycin-resistant enterococci; MBL: metallo-beta-lactamase.
|